Reduction in Intrasubject Variability in the Pharmacokinetic Response to Insulin After Subcutaneous Co-Administration with Recombinant Human Hyaluronidase in Healthy Volunteers-Reference-Cited by-同舟云学术

Reduction in Intrasubject Variability in the Pharmacokinetic Response to Insulin After Subcutaneous Co-Administration with Recombinant Human Hyaluronidase in Healthy Volunteers

Published:2011-10 Issue:10 Volume:13 Page:1039-1045
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Morrow Linda¹,Muchmore Douglas B.²,Ludington Elizabeth A.²,Vaughn Daniel E.²,Hompesch Marcus¹

Affiliation:

1. Profil Institute for Clinical Research, Chula Vista, California.

2. Halozyme Therapeutics Inc., San Diego, California.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2011.0115

Reference23 articles.

1. Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glulisine

2. Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

3. Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerated absorption of regular insulin administered via a vascularizing permeable microchamber implanted subcutaneously in diabetic Rattus norvegicus;PLOS ONE;2023-06-29

2. Accelerated absorption of regular insulin administered via a vascularizing permeable microchamber implanted subcutaneously in diabeticRattus norvegicus;2022-11-28

3. Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery;Expert Opinion on Drug Delivery;2021-09-29

4. Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements;Drug Design, Development and Therapy;2021-01

5. Recombinant human hyaluronidase PH20-mediated dermal spreading activity in mice is not altered by steroids, antihistamines, or salicylic acid;Drug Metabolism and Personalized Therapy;2020-12-25